Drug transport by reconstituted P‐glycoprotein in proteoliposomes
- 15 March 2001
- journal article
- research article
- Published by Wiley in European Journal of Biochemistry
- Vol. 268 (6) , 1687-1697
- https://doi.org/10.1046/j.1432-1327.2001.02041.x
Abstract
The P‐glycoprotein multidrug transporter (Pgp) is an active efflux pump for chemotherapeutic drugs, natural products and hydrophobic peptides. Pgp is envisaged as a ‘hydrophobic vacuum cleaner’, and drugs are believed to gain access to the substrate binding sites from within the membrane, rather than from the aqueous phase. The intimate association of both Pgp and its substrates with the membrane suggests that its function may be regulated by the biophysical properties of the lipid bilayer. Using the high affinity fluorescent substrate tetramethylrosamine (TMR), we have monitored, in real time, transport in proteoliposomes containing reconstituted Pgp. The TMR concentration gradient generated by Pgp was collapsed by the addition of either the ATPase inhibitor, vanadate, or Pgp modulators. TMR transport by Pgp obeyed Michaelis–Menten kinetics with respect to both of its substrates. The Km for ATP was 0.48 mm, close to the Km for ATP hydrolysis, and the Km for TMR was 0.3 µm. TMR transport was inhibited in a concentration‐dependent fashion by verapamil and cyclosporin A, and activated (probably by a positive allosteric effect) by the transport substrate colchicine. TMR transport by Pgp reconstituted into proteoliposomes composed of two synthetic phosphatidylcholines showed a highly unusual biphasic temperature dependence. The rate of TMR transport was relatively high in the rigid gel phase, reached a maximum at the melting temperature of the bilayer, and then decreased in the fluid liquid crystalline phase. This pattern of temperature dependence suggests that the rate of drug transport by Pgp may be dominated by partitioning of drug into the bilayer.Keywords
This publication has 52 references indexed in Scilit:
- ABC-ATPases, adaptable energy generators fuelling transmembrane movement of a variety of molecules in organisms from bacteria to humansJournal of Molecular Biology, 1999
- The Membrane Lipid Environment Modulates Drug Interactions with the P-Glycoprotein Multidrug TransporterBiochemistry, 1999
- BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTERAnnual Review of Pharmacology and Toxicology, 1999
- Interaction of P-Glycoprotein with Defined Phospholipid Bilayers: A Differential Scanning Calorimetric StudyBiochemistry, 1997
- Diagnosis and reversal of multidrug resistance in paediatric cancersEuropean Journal Of Cancer, 1996
- P-glycoprotein—A mediator of multidrug resistance in tumour cellsEuropean Journal Of Cancer, 1996
- The catalytic cycle of P‐glycoproteinFEBS Letters, 1995
- Cooperative P‐glycoprotein mediated daunorubicin transport into DNA‐loaded plasma membrane vesiclesFEBS Letters, 1994
- ATPase activity of partially purified P-glycoprotein from multidrug-resistant Chinese hamster ovary cellsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1992
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976